Securities code: 002584 securities abbreviation: Xilong Scientific Co.Ltd(002584) Announcement No.: 2022-009 Xilong Scientific Co.Ltd(002584)
Announcement of abnormal fluctuations in stock trading
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Introduction to abnormal fluctuations in stock trading
Xilong Scientific Co.Ltd(002584) (hereinafter referred to as “the company”) (Stock Code: 002584, stock abbreviation: Xilong Scientific Co.Ltd(002584) ) for three consecutive trading days (January 21, 2022, January 24, 2022, January 25, 2022), the cumulative decline deviation of the closing price exceeds 20%. According to the trading rules of Shenzhen Stock Exchange and other relevant regulations, the company’s stock trading belongs to the situation of abnormal fluctuation.
2、 Description of the company’s concern and verification
In view of the abnormal fluctuation of the company’s stock trading, the company has checked the relevant matters, and the relevant verification is explained as follows:
1. The information disclosed by the company in the early stage does not need to be corrected or supplemented.
2. The company received the “letter of concern” from Shenzhen Stock Exchange on January 24, and the company is actively verifying and organizing a reply. The company has not found any unpublished material information that may or has had a great impact on the stock trading price of the company reported by the public media recently.
3. The production and operation of the company are normal, and the internal and external business environment has not changed significantly.
4. The company’s transfer of 60% equity of its holding subsidiary Shandong aikewei Biotechnology Co., Ltd. is in progress. The company will continue to pay attention to the progress of this transaction and fulfill its obligation of information disclosure in time.
5. The company, the controlling shareholder and the actual controller do not have any major events that should be disclosed but not disclosed about the company or major events in the planning stage.
6. The controlling shareholders, actual controllers and persons acting in concert of the company did not buy or sell the company’s shares during the abnormal fluctuation of the company’s stock trading.
3、 Is there a statement that information should be disclosed but not disclosed
The board of directors of the company confirms that the company has no undisclosed matters or planning, negotiation, intention, agreement, etc. related to the matters that should be disclosed in accordance with the relevant provisions of the Listing Rules of Shenzhen Stock Exchange; The board of directors has not been informed that the company has undisclosed information that has a great impact on the trading price of the company’s shares and their derivatives that should be disclosed in accordance with the stock listing rules of Shenzhen Stock Exchange and other relevant provisions; The information disclosed by the company in the early stage does not need to be corrected or supplemented.
4、 Risk tips
(I) through self-examination, the company does not violate the fair disclosure of information.
(II) the board of directors of the company solemnly reminds investors that China Securities News, securities times, Shanghai Securities News and Securities Daily are the designated information disclosure newspapers of the company, and cninfo.com.cn It is the information disclosure website designated by the company. All information publicly disclosed by the company shall be subject to the official announcement published in the above designated newspapers and websites.
Please invest rationally and pay attention to investment risks.
It is hereby announced.
Xilong Scientific Co.Ltd(002584)
Board of directors
January 25, 2002
